Catalyst Event
Eli Lilly and Co (LLY) · Earnings Release
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
8/5/2026, 12:00:00 AM
Q2 2026 earnings release and conference call. Medium importance is estimated as earnings releases typically cause >5% price volatility scheduled.
Korean Translation
2026년 2분기 실적 발표 및 컨퍼런스 콜이며, 실적 발표는 통상적으로 5% 이상의 주가 변동을 초래하므로 중요도를 'Medium'으로 예상함. 예정됨.
Related Recent Events
Boston Scientific Corp (BSX) · Earnings Release
The Q2 2026 earnings release scheduled for 2026-07-29, for which high importance is estimated due to typical market volatility surrounding quarterly results, is expected.
7/29/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q2 2026 earnings release is scheduled for July 16, 2026; a price impact of at least 5% is estimated based on historical volatility, scheduled.
7/16/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Final dividend of HKD 0.20 per share ex-dividend on July 3, 2026; standard corporate action with minor price adjustment scheduled.
7/3/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Other
Ex-dividend date for the 2025 final dividend of HK$0.15 per share, which was announced on March 25, 2026. The payment date is July 15, 2026.
6/24/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Ex-dividend date (2026-06-19) for a proposed record-high annual dividend of CHF 4.70 per share; impact estimated at ~2% as dividend is record-high, scheduled.
6/19/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Annual General Meeting (2026-06-16) where shareholders will vote on proposals including the dividend; impact estimated at ~1% as it is a significant governance event, scheduled.
6/16/2026, 12:00:00 AM